Anoushka Sawhney, Sohini Das And Sachin P Mampatta

Stories by Anoushka Sawhney, Sohini Das And Sachin P Mampatta

Outlook gloomy for corporate share in direct tax mopup

Outlook gloomy for corporate share in direct tax mopup

Rediff.com   19 Apr 2025

Companies may foot less of the tax bill for some time yet. The corporate share of net direct tax collections has been lower in 2024-25 than in previous years. The corporate segment accounted for 45.6 per cent of total net direct tax collections as of March 16, compared to 48.1 per cent on the same date in 2023-24 (FY24).

Sun Pharma stock up 2.15% as US court clears alopecia drug launch

Sun Pharma stock up 2.15% as US court clears alopecia drug launch

Rediff.com   12 Apr 2025

Sun Pharmaceutical Industries stock ended 2.15 per cent higher on Friday after zooming by almost 5 per cent in the morning trade on the back of an announcement that a court ruling has cleared the deck for the India's largest pharmaceutical company to launch its alopecia drug Leqselvi in the United States.

Used-car Sales Likely To Outpace New Ones In FY26

Used-car Sales Likely To Outpace New Ones In FY26

Rediff.com   4 Apr 2025

India's used car market, which has been growing steadily at 10-12 per cent over the last 2-3 years, is expected to reach $40 billion in FY26.

Indian Pharma Gets Relief from Trump's Tariffs

Indian Pharma Gets Relief from Trump's Tariffs

Rediff.com   4 Apr 2025

Indian drugmakers supply 47 per cent of the generic medicine requirements in the US, and tariffs would have increased prices in the US domestic market for patients, who are already dealing with drug shortages.

Young Buyers Power Lamborghini's India Drive

Young Buyers Power Lamborghini's India Drive

Rediff.com   31 Mar 2025

India ranks 6th in the Asia-Pacific region for the Italian super luxury carmaker.

Discounts are back at car dealerships

Discounts are back at car dealerships

Rediff.com   21 Mar 2025

Dealers said the discounts this March are higher than the same month in the previous year.

PV Sales Face Bleak Outlook in 2024-25

PV Sales Face Bleak Outlook in 2024-25

Rediff.com   20 Mar 2025

Major Indian carmakers are preparing for sluggish domestic PV sales growth of just 1-2 per cent in FY26.

Diabetes Drug Price Drops 90%

Diabetes Drug Price Drops 90%

Rediff.com   20 Mar 2025

India is home to more than 100 million diabetics, and the demand for anti-diabetic drugs is on the rise -- the Rs 20,611 crore anti-diabetic drug market in India is growing at 9 per cent or so.

For Tesla, India is a challenge as well as opportunity

For Tesla, India is a challenge as well as opportunity

Rediff.com   19 Mar 2025

With India's EV penetration at just 2.5 per cent, the market presents an opportunity -- provided Tesla gets its pricing right.

India Ramps Up Gold Reserves...

India Ramps Up Gold Reserves...

Rediff.com   19 Mar 2025

The RBI added roughly 3 tonnes in 2025, taking its gold reserves to 879 tonnes as of January 31, 2025.

From Tesla to Mercedes, luxury carmakers head South

From Tesla to Mercedes, luxury carmakers head South

Rediff.com   11 Mar 2025

In 2024 alone, South India saw the highest rise in sales in the luxury segment, with Tamil Nadu reportedly registering a 19.3 per cent increase in premium car registrations from 2022-23

This will Likely Shape the Future of Pharma Inc

This will Likely Shape the Future of Pharma Inc

Rediff.com   8 Mar 2025

Indian pharmaceutical companies may have units abroad as part of "distributed manufacturing" across various locations, according to industry veterans. This may come about over the next five to 10 years.

'US tariff issue is an overhanging sword'

'US tariff issue is an overhanging sword'

Rediff.com   7 Mar 2025

Firodia talked about his plans for the EV-components business, and the components business at large for the group

Mankind Pharma Targets Anti-Obesity Drug

Mankind Pharma Targets Anti-Obesity Drug

Rediff.com   6 Mar 2025

'Obesity is a raging conversation globally now, and manufacturing of generics will pick up after the patent expires.'

Can Tesla Make In India For Below $23,000?

Can Tesla Make In India For Below $23,000?

Rediff.com   5 Mar 2025

The Indian automotive market offers around 1 million units annual volume opportunity at a price above $23,000.

Protein vs Junk Food: What Is India Spending More On?

Protein vs Junk Food: What Is India Spending More On?

Rediff.com   1 Mar 2025

Food budgets in urban areas spent less on protein as compared to beverages and processed foods, reveals the Household Consumption Expenditure survey data for 2023-24.

Gift City Helps Ahmedabad's Rise As Trading Powerhouse

Gift City Helps Ahmedabad's Rise As Trading Powerhouse

Rediff.com   28 Feb 2025

The share of Ahmedabad in the total value of trades on both the BSE and NSE is set to touch double digits for the third year in a row.

India Inc holds breath for Trump's new tariffs to kick in

India Inc holds breath for Trump's new tariffs to kick in

Rediff.com   27 Feb 2025

Industry insiders in India warn that any such move in the pharmaceutical sector could be counterproductive for the US as it may face increased drug shortages if tariffs are imposed on such imports.

Foreign companies' tax burden at record low in India

Foreign companies' tax burden at record low in India

Rediff.com   24 Feb 2025

Foreign companies now pay less tax relative to their earnings than at any time in more than three decades. Foreign private companies paid 24.36 per cent of their pre-tax profit as tax in 2023-24, show numbers from the Centre for Monitoring Indian Economy (CMIE).

Why Tesla Entry is No Major Threat

Why Tesla Entry is No Major Threat

Rediff.com   24 Feb 2025

Tesla needs to either sell the same models with reduced features to lower the cost for Indian market, or incur losses.